Corza Medical, a new venture backed by the financial firepower of private equity giant GTCR, is looking to build a surgical tool supplier that its executive chairman Greg Lucier says can compete with “almost monopolistic” leaders in the space.
To mount the challenge, Corza acquired Surgical Specialties Corp., a supplier of surgical sutures and ophthalmic knives. Corza will use this beachhead in Westwood, Mass., to build a pipeline of acquired assets including TachoSil, a surgical patch product line Corza acquired from Takeda Pharmaceuticals last year.
In an interview with the DeviceTalks Weekly podcast, Lucier, the former CEO of spinal company NuVasive (NSDQ:NUVA) and diagnostic company Life Technologies, said management believes “there is an opening for a pretty good-sized surgical tools and technologies company to compete against the Ethicons and the Medtronics of the world.”
Lucier said the two Goliaths have reached a size that makes them “almost monopolistic with their bundling. Customers are looking for a choice where they can get that exceptional value with remarkable service. That’s what we’re going to do with Corza Medical.”
Original Article: https://www.medicaldesignandoutsourcing.com/corza-medical-set-to-take-on-almost-monopolistic-surgical-giants/
